Rehabilitation Intervention for COPD Combined With Cardiovascular and Cerebrovascular Diseases

NARecruitingINTERVENTIONAL
Enrollment

50,000

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2028

Conditions
Respiratory DiseasesCardiovascular DiseasesCerebrovascular Diseases
Interventions
COMBINATION_PRODUCT

Pulmonary Rehabilitation Care Group

participants were randomized (1:1) to either the optimized or routine group via a computer-generated random number table. The Routine Care Group received treatment for three months and follow-up with medications prescribed according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2025 Report. The Pulmonary Rehabilitation Care Group received the Pulmonary rehabilitation exercise and usual care for three months. Next, Observe the changes in the improvement of acute exacerbation frequency (times/year/person),CAT Scoring and St. George's Respiratory Questionnaire (SGRQ), as well as lung ventilation and diffusion function of the two groups of patients one year after the intervention.

OTHER

The Routine Care (Non-Pharmacological and Pharmacological Treatments ) Group

participants were randomized (1:1) to either the optimized or routine group via a computer-generated random number table. The Routine Care Group received treatment for three months and follow-up with medications prescribed according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2025 Report. Next, Observe the changes in the improvement of acute exacerbation frequency (times/year/person),CAT Scoring and St. George's Respiratory Questionnaire (SGRQ), as well as lung ventilation and diffusion function one year after the intervention.

Trial Locations (1)

430022

RECRUITING

Union hospital, Tongji Medical college, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER